Clinical Trials Directory

Trials / Unknown

UnknownNCT04742114

Effect of EPAP Device on Emphysema and Lung Bullae

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Qilu Hospital of Shandong University · Academic / Other
Sex
All
Age
75 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the safety and the effects and of the application of Expiratory Positive Airway Pressure (EPAP) device on Dynamic Hyperinflation and dyspnea in patients with Emphysema and pulmonary bullae.

Detailed description

The trial will last for six months. Patients will be collected clinical and anthropometric data by using questionnaires initially. Patients will have the pulmonary function test and CT scan and conduct 6MWT every two months. And Borg scale data will be collected every two months. The application of EPAP (15cmH2O) via face mask will be randomized with the help of opaque envelopes.

Conditions

Interventions

TypeNameDescription
DEVICEuse the face mask with Expiratory Positive Airway Pressure(EPAP).The subjects were divided into two groups. The first group use the face mask without EPAP, and the other group use the face mask with EPAP.
DEVICEuse the face mask without Expiratory Positive Airway Pressure(EPAP).The subjects were divided into two groups. The first group use the face mask without EPAP, and the other group use the face mask with EPAP.

Timeline

Start date
2021-07-31
Primary completion
2022-11-10
Completion
2022-11-20
First posted
2021-02-05
Last updated
2022-03-29

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04742114. Inclusion in this directory is not an endorsement.